Nakayama Masaaki, Terawaki Hiroyuki
Department of Nephrology and Hypertension, Fukushima Medical University School of Medicine, Fukushima, Japan.
Int J Urol. 2014 Aug;21(8):755-61. doi: 10.1111/iju.12445. Epub 2014 Mar 27.
Peritoneal dialysis is established as a first-line standard renal replacement therapy for end-stage renal disease. However, the development of encapsulating peritoneal sclerosis has been a critical complication among long-term peritoneal dialysis patients. During the past decade, multidisciplinary approaches have been used to suppress encapsulating peritoneal sclerosis. The present article reviews the historical and present status of encapsulating peritoneal sclerosis in Japan.
腹膜透析已被确立为终末期肾病的一线标准肾脏替代疗法。然而，包裹性腹膜硬化的发展一直是长期腹膜透析患者的关键并发症。在过去十年中，多学科方法已被用于抑制包裹性腹膜硬化。本文回顾了日本包裹性腹膜硬化的历史和现状。
